全文获取类型
收费全文 | 5118篇 |
免费 | 311篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 46篇 |
儿科学 | 98篇 |
妇产科学 | 118篇 |
基础医学 | 695篇 |
口腔科学 | 51篇 |
临床医学 | 706篇 |
内科学 | 960篇 |
皮肤病学 | 86篇 |
神经病学 | 552篇 |
特种医学 | 122篇 |
外科学 | 638篇 |
综合类 | 47篇 |
一般理论 | 3篇 |
预防医学 | 478篇 |
眼科学 | 102篇 |
药学 | 400篇 |
中国医学 | 1篇 |
肿瘤学 | 346篇 |
出版年
2023年 | 24篇 |
2022年 | 53篇 |
2021年 | 96篇 |
2020年 | 64篇 |
2019年 | 64篇 |
2018年 | 80篇 |
2017年 | 71篇 |
2016年 | 102篇 |
2015年 | 114篇 |
2014年 | 145篇 |
2013年 | 205篇 |
2012年 | 303篇 |
2011年 | 359篇 |
2010年 | 187篇 |
2009年 | 226篇 |
2008年 | 331篇 |
2007年 | 374篇 |
2006年 | 390篇 |
2005年 | 386篇 |
2004年 | 288篇 |
2003年 | 281篇 |
2002年 | 255篇 |
2001年 | 80篇 |
2000年 | 70篇 |
1999年 | 71篇 |
1998年 | 73篇 |
1997年 | 49篇 |
1996年 | 56篇 |
1995年 | 35篇 |
1994年 | 35篇 |
1993年 | 47篇 |
1992年 | 53篇 |
1991年 | 39篇 |
1990年 | 30篇 |
1989年 | 34篇 |
1988年 | 34篇 |
1987年 | 27篇 |
1986年 | 25篇 |
1985年 | 17篇 |
1984年 | 12篇 |
1983年 | 22篇 |
1982年 | 14篇 |
1981年 | 14篇 |
1980年 | 19篇 |
1979年 | 16篇 |
1977年 | 10篇 |
1973年 | 11篇 |
1972年 | 9篇 |
1971年 | 13篇 |
1969年 | 14篇 |
排序方式: 共有5449条查询结果,搜索用时 15 毫秒
1.
2.
L. Misery E. Weisshaar E. Brenaut A.W.M. Evers F. Huet S. Ständer A. Reich E. Berardesca E. Serra-Baldrich J. Wallengren D. Linder J.W. Fluhr J.C. Szepietowski H. Maibach for the Special Interest Group on sensitive skin of the International Forum for the Study of Itch 《Journal of the European Academy of Dermatology and Venereology》2020,34(2):222-229
The special interest group on sensitive skin of the International Forum for the Study of Itch previously defined sensitive skin as a syndrome defined by the occurrence of unpleasant sensations (stinging, burning, pain, pruritus and tingling sensations) in response to stimuli that normally should not provoke such sensations. This additional paper focuses on the pathophysiology and the management of sensitive skin. Sensitive skin is not an immunological disorder but is related to alterations of the skin nervous system. Skin barrier abnormalities are frequently associated, but there is no cause and direct relationship. Further studies are needed to better understand the pathophysiology of sensitive skin – as well as the inducing factors. Avoidance of possible triggering factors and the use of well-tolerated cosmetics, especially those containing inhibitors of unpleasant sensations, might be suggested for patients with sensitive skin. The role of psychosocial factors, such as stress or negative expectations, might be relevant for subgroups of patients. To date, there is no clinical trial supporting the use of topical or systemic drugs in sensitive skin. The published data are not sufficient to reach a consensus on sensitive skin management. In general, patients with sensitive skin require a personalized approach, taking into account various biomedical, neural and psychosocial factors affecting sensitive skin. 相似文献
3.
4.
Arjenne H.M. Gussenhoven Amika S. Singh S. Theo Goverts Marten van Til Johannes R. Anema Sophia E. Kramer 《International journal of audiology》2015,54(8):507-517
Objective: A multidisciplinary vocational rehabilitation programme, the Vocational Enablement Protocol (VEP) was developed to address the specific needs of employees with hearing difficulties. In the current study we evaluated the process of implementing the VEP in audiologic care among employees with hearing impairment. Design: In conjunction with a randomized controlled trial, we collected and analysed data on seven process parameters: recruitment, reach, fidelity, dose delivered, dose received and implemented, satisfaction, and perceived benefit. Study sample: Sixty-six employees with hearing impairment participated in the VEP. The multidisciplinary team providing the VEP comprised six professionals. Results: The professionals performed the VEP according to the protocol. Of the recommendations delivered by the professionals, 31% were perceived as implemented by the employees. Compliance rate was highest for hearing-aid uptake (51%). Both employees and professionals were highly satisfied with the VEP. Participants rated good perceived benefit from it. Conclusions: Our results indicate that the VEP could be a useful treatment for employees with hearing difficulties from a process evaluation perspective. Implementation research in the audiological setting should be encouraged in order to further provide insight into parameters facilitating or hindering successful implementation of an intervention and to improve its quality and efficacy. 相似文献
5.
K U Chu S Higashide B M Evers S Rajaraman J Ishizuka C M Townsend Jr J C Thompson 《Annals of surgery》1994,220(4):570-577
OBJECTIVE: The authors determined whether bombesin could improve survival from methotrexate (MTX)-induced enterocolitis. SUMMARY BACKGROUND DATA: Bombesin prevents gut mucosal atrophy, which is produced by feeding rats an elemental diet. Administration of MTX produces a lethal enterocolitis in rats fed an elemental diet. METHODS: On treatment day 0, 60 rats were divided randomly into three groups and fed an elemental diet (Vivonex TEN, Sandoz, Minneapolis, MN) as the only source of nutrition. Groups were subdivided further to receive either saline or bombesin (10 micrograms/kg, subcutaneously, three times a day) beginning either on day 0 or day 14. Methotrexate (20 mg/kg, intraperitoneally) was given to all rats 14 days after the start of an elemental diet. RESULTS: Bombesin prevented the mucosal atrophy in the ileum produced by the elemental diet and significantly decreased mortality in rats given MTX (whether given as a pretreatment or at the time of MTX administration). CONCLUSION: Bombesin significantly improved survival in a lethal model of MTX-induced enterocolitis, possibly by maintaining gut mucosal structure. Administration of bombesin to patients receiving chemotherapy may be clinically useful in preventing the severe enterocolitis induced by various chemotherapeutic agents. 相似文献
6.
7.
8.
Pieter M. Groenendijk August A. B. Lycklama Nijeholt Theo J. Ouwerkerk Ubi van den Hombergh 《Neuromodulation》2007,10(4):363-368
Objective. We studied long‐term clinical efficacy of sacral neuromodulation (SNM) therapy in patients with refractory urgency incontinence (UI), urgency/frequency (UF) and voiding difficulty (VD), together with urodynamic data at baseline and six months postimplant. Materials and Methods. Twenty‐two patients were implanted with a neurostimulator after a positive response to a percutaneous nerve evaluation test defined as a greater than 50% improvement in symptoms. Results. At five‐year follow‐up, the number of incontinent episodes and pad usage per day decreased significantly in 10 out of 15 UI patients. Two of five UF patients were successfully treated with SNM; the number of daily voids for all UF patients decreased from 25 to 19 and average voided volume increased from 98 to 212 mL. One of the two VD patients was able to void to completion. Mean first sensation of filling at the six‐month urodynamic investigation for the UI and UF patients increased from 78 to 241 mL and 141 to 232 mL, respectively, and the maximum bladder capacity increased from 292 to 352 mL and 223 to 318 mL, respectively. Five of 22 patients underwent device explant and one patient still has an inactive stimulator implanted. Conclusion. SNM is an effective treatment modality that offers sustained clinical benefit in the majority of patients with refractory UI, UF, and VD that do not respond to other, more conservative therapies. 相似文献
9.
Yawarat Porapakkham Chalapati Rao Junya Pattaraarchachai Warangkana Polprasert Theo Vos Timothy Adair Alan D Lopez 《Population health metrics》2010,8(1):14